X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://endpts.com/takeda-tees-up-priority-review-for-storied-cmv-drug-from-its-62b-shire-buyout/
https://endpts.com/news-briefing-fda-approves-ointment-for-precancer-skin-lesions-takeda-nabs-priority-review-for-shire-drug/
https://www.fiercepharma.com/pharma-asia/takeda-offers-japanese-staffers-early-retirement-post-shire-slimdown
https://www.prnewswire.com/news-releases/antianxiety-and-antidepressant-effects-from-a-single-dose-of-psychedelic-drug-persist-years-later-in-cancer-patients-300991201.html
https://www.fiercepharma.com/special-report/top-15-m-a-mistakes
https://www.fiercebiotech.com/biotech/yumanity-snags-a-cmo-as-shire-keeps-bleeding-execs
https://in.reuters.com/article/us-takeda-pharma-divestiture-stada-arzne/takeda-to-sell-portfolio-of-select-drugs-for-660-million-idINKBN1XF0X6
https://www.fiercebiotech.com/biotech/ipsen-grabs-new-r-d-lead-as-shire-s-neuro-head-leaves-amid-takeda-takeover
https://www.fiercebiotech.com/biotech/astrazeneca-spinout-entasis-nabs-shire-exec-as-cmo
https://www.fiercepharma.com/pharma/hemophilia-rivalry-pressures-post-shire-takeda-but-ceo-weber-points-to-14-drugs-for-growth
Market Place
Share 
